Fortin Ensign, Shannon P. http://orcid.org/0000-0002-7433-528X
Gaulin, Charles http://orcid.org/0000-0001-6943-4614
Hrachova, Maya
Ruff, Michael
Harahsheh, Ehab
Vicenti, Kevin
Castro, Januario
Munoz, Javier
Rosenthal, Allison
Mrugala, Maciej M. http://orcid.org/0000-0002-4027-7173
Article History
Accepted: 30 October 2022
First Online: 16 December 2022
Declarations
:
: Dr. Fortin Ensign has nothing to disclose. Dr. Gaulin has nothing to disclose. Dr. Hrachova has nothing to disclose. Dr. Ruff has nothing to disclose. Dr. Harahsheh has nothing to disclose. Dr. Vicenti has nothing to disclose. Dr. Castro has nothing to disclose. Dr. Munoz reports personal fees from Pharmacyclics/Abbvie, Bayer, Gilead/Kite Pharma, Pfizer, Janssen, Juno/Celgene, BMS, Kyowa, Alexion, Fosunkite, Innovent, Seattle Genetics, Debiopharm, Karyopharm, Genmab, ADC Therapeutics, Epizyme, Beigene, Servier, Novartis, Morphosys/Incyte, Mei pharma, Zodiac, grants from Bayer, Gilead/Kite Pharma, Celgene, Merck, Portola, Incyte, Genentech, Pharmacyclics, Seattle Genetics, Janssen, Millennium, other from Targeted Oncology, OncView, Curio, Kyowa, Physicians’ Education Resource, Dava, Global clinical insights, MJH, Shanghai Youyao, and Seattle Genetics, other from Gilead/Kite Pharma, Kyowa, Bayer, Pharmacyclics/Janssen, Seattle Genetics, Acrotech/Aurobindo, Beigene, Verastem, AstraZeneca, Celgene/BMS, Genentech/Roche, during the conduct of the study. Dr. Rosenthal has nothing to disclose. Dr. Mrugala has nothing to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.